## PNW: Pinnacle West Capital Corporation - XLU: Utilities

### Executive Summary

No thesis match: MRS_10 -0.7% below STRENGTH zone (3.0-6.0%); PEG 3.66 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($85.22)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. December 2026 Options Now Available For Pinnacle West Capital (PNW)**
- Source: Nasdaq | 20251222T160925 | Somewhat-Bullish | Relevance: 100%
- New options for Pinnacle West Capital (PNW) expiring in December 2026 are now available, offering potential opportunities for options traders. The article highlights an $80.00 strike put contract which could reduce the cost basis for investors interested in buying PNW shares, and a $90.00 strike call contract that could provide a 5.98% return for covered call sellers. Both strategies present different risk/reward profiles based on the stock's future performance.

**2. Perpetual Ltd Purchases 73,419 Shares of Pinnacle West Capital Corporation $PNW**
- Source: MarketBeat | 20251220T125614 | Bullish | Relevance: 100%
- Perpetual Ltd increased its stake in Pinnacle West Capital Corporation by 17.5% in the third quarter, acquiring 73,419 additional shares, bringing their total to 493,105 shares valued at approximately $44.21 million. Pinnacle West Capital (NYSE:PNW) reported strong quarterly earnings, beating expectations with EPS of $3.39 and revenue of $1.82 billion, and declared a quarterly dividend of $0.91. Despite financial successes, analysts generally rate the stock as "Hold" with a consensus target price of $96.58.

**3. Pinnacle West Capital Corporation (NYSE:PNW) Receives Average Recommendation of "Hold" from Analysts**
- Source: MarketBeat | 20251222T060858 | Somewhat-Bullish | Relevance: 100%
- Pinnacle West Capital Corporation (NYSE:PNW) has received a "Hold" rating from analysts, with ten recommending a hold and five a buy, leading to an average 12-month price target of $96.58. The company recently exceeded quarterly earnings estimates and declared a quarterly dividend of $0.91, equating to an annualized yield of 4.2%. Institutional investors collectively own over 91% of PNW shares, with several firms significantly increasing their stakes.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | UBS | $95 | $94 | +1% |
| 2025-12-12 | Keybanc | $0 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | UBS | main | Neutral |
| 2025-12-12 | Keybanc | down | Sector Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Capital Research Glo: 13.2% (+5.0%)
- Vanguard Group Inc: 12.3% (-0.7%)
- Blackrock Inc.: 9.1% (+2.7%)
- Barrow, Hanley Mewhi: 6.0% (+8.5%)
- State Street Corpora: 5.6% (+0.5%)

### Key Risks

1. Valuation stretched: PEG 3.7x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.66 signals overvaluation risk, limited margin of safety. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.5B |
| Beta | 0.53 |
| 52W Range | $81.47 - $96.50 |
| Short Interest | 7.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.66 |
| Forward P/E | 18.7 |
| Current P/E | 17.5 |
| YoY Growth | -6.6% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 1.6% to -0.7% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.7pp (needs >3.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. RSI neutral at 45. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.73% (CS: 38) | Neutral |
| RSI_14 | 45.3 | Neutral |
| MACD Histogram | 0.04 | Bullish |
| vs SMA20 | 0.992x | Below |
| vs SMA50 | 0.979x | Below |
| vs SMA200 | 0.968x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $87.68
- **Stop Loss:** $85.22 (2.8% risk)
- **Target:** $90.14 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 243
- **Position Value:** $21,306.24
- **Portfolio %:** 21.31%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-24 (Est: $0.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.09 | $3.39 | +9.7% |
| 2025Q2 | $1.57 | $1.58 | +0.5% |
| 2025Q1 | $0.02 | $-0.04 | -340.0% |
| 2024Q4 | $-0.15 | $-0.06 | +60.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*